pharmaphorum

Earendil raises $787m as lead TL1A antibody starts phase 2

Earendil Labs has raised an impressive $787 million in financing for its AI-powered drug discovery and development platform, which has already attracted some big-ticket deals with pharma group Sanofi.
The New Indian Express

Let's lead by example, says BRS leader KTR

BRS working president KT Rama Rao also warned of legal action against those who are trying to drag his name into the drug raid controversy. HYDERABAD: BRS working president KT Rama Rao welcomed TPCC ...
PharmiWeb

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company ...
Semiconductor Engineering

Automated Multiphysics For Successful 3D-IC Design

For design teams adopting 3D-IC architectures, the relentless pursuit of performance and reliability brings a familiar, yet ...
Las Vegas Sun

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...
PharmiWeb

Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and ...

The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4) modulator, met its primary endpoint and also demonstrated a statistically significant relationship ...
The State Journal-Register

Grenova Appoints New Chief Executive Officer to Lead Next Phase of Growth Across Global Automation Platform

COLORADO SPRINGS, CO, UNITED STATES, March 25, 2026 /EINPresswire.com/ — Grenova today announced the appointment of Ted Hull as Chief Executive Officer. Hull will ...